| |
|
|
|
Citius Pharmaceuticals Inc  
|
|
1.26 0.01 (0.01%) |
01-22 16:00 |
|
Open: |
1.29 |
Pre close: |
1.25 |
Target:
|
1.58
|
|
High: |
1.3 |
Low: |
1.21 |
Resistance:
|
1.35
1.58
|
|
Volume: |
814,047 |
Market Cap: |
70M |
Support:
|
1.12
0.97
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.23
 |
MACD |
MACD(12,26):
|
0.05 |
|
MA(20): |
1.12 |
Signal(12,26,9): |
0.03 |
|
MA(100): |
1.04 |
Stochastic Oscillator |
%K(14,3):
|
81.14  |
|
MA(250): |
0.98 |
%D(3): |
86.30 |
|
Average Volume(K) |
3-Month: |
72693
|
52-Week |
High:
|
1.97 |
|
10-Days: |
116476 |
Low: |
0.41 |
|
RSI |
RSI(14):
|
63.36 |
Change(%): |
11.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.448 |
Return on Equity (ttm) |
-57.7 |
Shares Out. (M) |
55.58 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-27.5 |
Shares Float (M) |
37.46 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
22.15 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
13.89 |
|
Forward EPS |
-1.170 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
1650 |
|
Book Value (p.s.) |
0.610 |
EBITDA (p.s.) |
-0.319 |
P/E |
-2.81 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.07 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-16.93 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-10.34 |
P/CF |
-4.14 |
|
|
|
|
|
|
